Recruiting
Prospective Asian Multicenter Prostate Cancer Focal Therapy Study (ProAMFocal)
About this study
This is a multicenter observational study of patients undergoing focal therapy for prostate cancer in Asia
- Condition
- Prostate Cancer
- Tested
- Focal Therapy for Prostate Cancer
- Sponsor
- Singapore General Hospital
Who can join
- Age
- 40 to 85 years
- Sex
- Male only
- Healthy volunteers
- Not accepted
Inclusion 10
- Minimum age: 40 years
- Maximum age: 85 years
- Eligible sex: Male
- Study condition: Prostate Cancer
- Prostate Adenocarcinoma
- Maximum Gleason score 4+4
- Maximum cancer volume 1.5 ml (up to 2 lesions) or 3 ml (single lesion)
- Maximum Prostate Specific Antigen (PSA) level 15 ng/dl
- Maximum clinical stage T2c
- American Society of Anesthesiologist Criteria 2 or less
Exclusion 1
- Extra-prostatic Extension on multi parametric magnetic resonance imaging (mpMRI); capsular contact is permitted
Where
1 site, 1 recruiting
Singapore General Hospital
Singapore, Singapore
Contact
-
Kae Jack Tay, MBBS
63214693 tay.kae.jack@singhealth.com.sg
Potential match only. Final eligibility is determined by the study team.